[1] Cooper MK, Porter JA, Young KE, et al. Teratogen-mediated inhibition of target tissue response to Shh signaling[J]. Science, 1998, 280(5369):1603-1607.
[2] 汪廷乐,肖翠翠,陈万涛,等. 人腮腺多形性腺瘤细胞的体外培养[J]. 中国口腔颌面外科杂志,2011,9(2):108-111.
[3] Mimeault M, Moore E, Moniaux N, et al. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells[J]. Int J Cancer,2006,118(4):1022-1031.
[4] 谭小尧,张兴安,李果,等. 腮腺多形性腺瘤改良术式与传统术式的对比研究[J]. 口腔颌面外科杂志,2011,21(5):338-340.
[5] Paiva KB, Silva-Valenzuela MG, Massironi SM, et al. Differential Shh, Bmp and Wnt gene expressions during craniofacial development in mice[J]. Acta Histochem, 2010, 112(5):508-517.
[6] Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance[J]. Nat Rev Cancer,2003,3(12):903-911.
[7] Marini KD, Payne BJ, Watkins DN, et al. Mechanisms of Hedgehog signalling in cancer[J]. Growth Factors, 2011,29(6):221-234.
[8] 肖翠翠,汪廷乐,宋萌,等. Gli2基因在涎腺多形性腺瘤中的表达及其意义[J].口腔颌面外科杂志, 2010,20(6):384-388.
[9] Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells[J]. Cancer Res, 2007, 67(22): 10642-10646.
[10] Iannolo G, Conticello C, Memeo L, et al. Apoptosis in normal and cancer stem cells[J]. Crit Rev Oncol Hematol,2008,66(1):42-51.
[11] Qiao L, Wong BC. Targeting apoptosis as an approach for gastrointestinal cancer therapy[J]. Drug Resist Updat,2009,12(3):55-64.
[12] Chen XL, Cao LQ, She MR, et al. Gli-1 siRNA induced apoptosis in Huh7 cells[J]. World J Gastroenterol,2008,14(4):582-589.
[13] Manjunatha BS, Kumar GS, Raghunath V. Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors[J]. Med Oral Patol Oral Cir Bucal,2011,16(4):e503-e507.
[14] AL-Rawi NH, Omer H, AL Kawas S. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors[J]. J Oral Pathol Med,2010, 39(1):48-55.
[15] Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2[J]. Cancer Res,2004,64(21):7724-7731.
[16] Bigelow RL, Chari NS, Unden AB, et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1[J]. J Biol Chem,2004,279(2):1197-1205.
[17] Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation[J]. Curr Mol Med, 2009, 9(7):873-886.
[18] Bar EE, Chaudhry A, Farah MH, et al. Hedgehog signaling promotes medulloblastoma survival via Bc/II [J]. Am J Pathol, 2007, 170(1):347-355.
[19] Chen XL, Cheng QY, She MR, et al. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro[J]. Arch Med Res, 2010,41(5):315-323.
[20] Han ME, Lee YS, Baek SY, et al. Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2[J]. Int J Mol Sci, 2009,10(7):3033-3043.
[21] McCall TD, Pedone CA, Fults DW. Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice[J]. Cancer Res,2007,67(11):5179-5185.
[22] Kurita S, Mott JL, Cazanava SC, et al. Hedgehog inhibition promotes a switch from Type Ⅱ to Type Ⅰ cell death receptor signaling in cancer cells[J]. PLoS One, 2011,6(3):e18330. |